MAPK1 and neoplasm: In conclusion, miR-550a-3p plays a tumor-suppressor role in breast cancer initiation and progression by directly targeting and repressing ERK1 and ERK2 which inhibits activation of downstream ERK/RSK cascades and results in suppression of cancer cell viability, survival, migration, invasion, tumorigenesis and metastasis.